SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001585364-20-000010
Filing Date
2020-02-27
Accepted
2020-02-27 08:02:39
Documents
16
Period of Report
2020-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cy19q4earningsrelease8.htm   iXBRL 8-K 89108
2 EXHIBIT 99.1 cy19q4ex991pressrelease.htm EX-99.1 1778414
8 image0a01a01a01a82.jpg GRAPHIC 16416
  Complete submission text file 0001585364-20-000010.txt   2111597

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20200227.xsd EX-101.SCH 4579
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prgo-20200227_cal.xml EX-101.CAL 618
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20200227_def.xml EX-101.DEF 1468
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20200227_lab.xml EX-101.LAB 27015
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20200227_pre.xml EX-101.PRE 14036
14 EXTRACTED XBRL INSTANCE DOCUMENT cy19q4earningsrelease8_htm.xml XML 4281
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 20658534
SIC: 2834 Pharmaceutical Preparations